HOPKINTON, Mass., May 11, 2011 /PRNewswire/ -- Caliper Life Sciences, Inc. (NASDAQ: CALP) today announced a partnership with The Genome Analysis Centre (TGAC), a leading high throughput sequencing and analysis center based in Norwich, UK establishing TGAC as a National Reference Site. TGAC will implement Caliper's NGS Bundle, which includes the Sciclone NGS Workstation, LabChip GX, and LabChip XT, providing TGAC with a suite of automation and microfluidic solutions for a flexible and scalable sequencing sample preparation pipeline that offers superior sample tracking and reproducibility.
"We are pleased to become the first UK-based sequencing center to implement Caliper's suite of next generation sequencing tools," said Dr Melanie Febrer, TGAC's Library Construction Manager. "These automated solutions will enable us to develop a high throughput system for both sample preparation and post library processes."
"We are excited to be working with TGAC," said Kevin Hrusovsky, President and CEO of Caliper Life Sciences. "Caliper's automated solutions for sample preparation are uniquely capable of providing the sensitivity and reproducibility necessary for sequencing sample processing. Our solutions have been widely adopted by the sequencing community and partnerships with pioneering groups like TGAC are critical to the development of solutions that advance our understanding of disease."
Caliper has developed a complete suite of next generation sequencing tools including the Sciclone® NGS Workstation for library construction and sequence capture protocols, the high throughput LabChip® GX for library quantification and quality control, and the preparative LabChip XT that replaces the tedious and inconsistent gel isolation steps for library preparation. For additional information about Caliper's solutions for high throughput sequencing, please visit '/>"/>
|SOURCE Caliper Life Sciences, Inc.|
Copyright©2010 PR Newswire.
All rights reserved